Walt Disney Concert Hall

Roy and Edna Disney / CALARTS Theater (REDCAT)

When FDA was asked by CALARTS to work with the faculty and staff to plan an expansion of the college’s arts facilities, it was clear that the school’s performance space would need to accommodate an ambitious program. Therefore, REDCAT’s performance and screening space in the lower level of Disney Concert Hall in Los Angeles was designed for maximum flexibility.

The stage can be transformed into several configurations, from thrust and end stage to completely in-the-round. The space can accommodate an audience as large as 277. Eight movable seating wagons, and a covered “pit” containing three additional rows that can be revealed or decked as needed, can be reconfigured in many ways.

FDA’s concerns for both flexibility and cost-conscious design led to the decision to line the performance space with hinged doors. These are easily adjusted to optimize the acoustic properties of the space depending upon the requirements of each performance type.

REDCAT is FDA’s second theatre for CALARTS. The original “Modular” theatre that was designed in 1972 remains in use.

  • Client: California Institute of the Arts
  • Architect: Frank Gehry
  • Completion Year: 2003
  • Location: Los Angeles, California
  • Acoustician: Yasuhisa Toyota
  • Building Size: 7,140 s.f.
  • Capacity: 277 seats


Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
error: Content is protected. Please reach out to rhackman@fda-online.com for any materials needed. Thank you